Bradley Moore, MD
Surgery · Kansas City, MONPI 1922047646
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $83,857 of the $109,952 with a category attached, or 76.3%. 14 manufacturers reported payments, led by Medical Device Business Services, Inc. at 51.4% of the total. Reporting peaked in 2019 at $37,062 and has fallen 59.5% since, to $15,021 in 2025. Among surgery clinicians in MO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 170 payments — averaging $646.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medical Device Business Services, Inc.$56K
- Johnson & Johnson$33K
- Intuitive Surgical$20K
- W. L. Gore & Associates, Inc.$141
- Covidien LP$131
- Davol Inc.$116
- plus $342 from 8 others
What the payments were for
- Consulting fees$83,85776%
- Travel & lodging$4,0314%
- Food & beverage$7,0636%
- Education$15,00014%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medical Device Business Services, Inc. | 35 | $56,471 |
| Johnson & Johnson | 56 | $32,698 |
| Intuitive Surgical | 63 | $20,053 |
| W. L. Gore & Associates, Inc. | 2 | $141 |
| Covidien LP | 1 | $131 |
| Davol Inc. | 1 | $116 |
| Nevro Corp. | 2 | $116 |
| Baxter Healthcare | 2 | $75 |
| TELA Bio, Inc. | 1 | $40 |
| Ambu Inc. | 3 | $30 |
| Tolmar, Inc. | 1 | $26 |
| Calyxo, Inc. | 1 | $21 |
| Dendreon Pharmaceuticals LLC | 1 | $20 |
| Astellas Pharma US Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$109,952 in reported general payments places this provider in the 95th percentile of 612 surgery providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Famotidine | 29 | $352 |
| Pantoprazole Sodium | 30 | $198 |
| Oxycodone Hcl | 104 | $192 |
| Esomeprazole Magnesium | 12 | $117 |
| Ondansetron OdtOndansetron | 19 | $91 |
Paid to pharmacies, not to this prescriber.
Other surgery in Kansas City
- George SorensenKansas City$80K
- Mohsin SolimanKansas City$46K
- David ShanbergKansas City$24K
- Heather KlepaczKansas City$17K
- James ScottSaint Louis$307K
- Omar GuerraSaint Louis$249K
- John TannColumbia$216K
- Mark DrakeSaint Louis$212K
- Adeel KhanSaint Louis$204K
- Michael AwadSaint Louis$176K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.